The federal government shutdown has finally ended, and billions of dollars in federal funding are flowing again. While the economic impact of the six-week disruption was significant, experts say the long-term effects will be relatively modest. During the shutdown, millions of Americans faced food insecurity, flight delays, and cancellations, leading to a decline in consumer … Read more
Pfizer is selling its remaining stake in partner BioNTech, which developed the Comirnaty COVID-19 vaccine. This comes as Pfizer’s stock fell 5% before the market opened on Thursday. The decision may impact the US pharma giant’s ability to benefit from BioNTech’s future vaccine sales. Source: https://seekingalpha.com/news/4521405-pfizer-divest-remaining-stake-biontech
Canary Capital, a firm behind the first US Spot XRP ETF, is expanding its niche crypto product offerings with a new filing for an exchange-traded fund tied to MOG Coin, a cat-themed memecoin. The MOG Coin has seen a decline of 78% in the past year as the broader memecoin sector faces challenges. MOG Coin, … Read more
Major media companies including Paramount and Comcast are preparing to submit bids for Warner Bros., with some of the parties eyeing the deadline of November 20. These bidders aim to acquire the struggling studio, which has seen its share price decline recently. The deal is expected to be completed by the end of the year, … Read more
Prediction marketplace founder Shayne Coplan spoke at the Cantor Fitzgerald conference in Miami, where he discussed building Polymarket alone and with little money using blockchain technology from his bedroom. Coplan argued that prediction markets offer better information than polls or sportsbooks by pricing real-world outcomes through peer-to-peer trading. He sees future use cases for Polymarket … Read more
Get a unified view of your Copilot coding agent tasks directly in Visual Studio Code. Easily track session logs, task status, and collaborate with Copilot without switching between apps. With the new feature, you can seamlessly switch between tasks and see progress at a glance. Continue working where Copilot left off by opening sessions in … Read more
Pfizer is selling off its remaining stake in COVID-19 vaccine partner BioNTech. The US drugmaker will sell around 4.55 million shares at a price of $108-$111.70 per share, worth about $508 million if sold at the high end. This is part of Pfizer’s efforts to divest pandemic-related assets and focus on future collaborations. Source: https://www.bloomberg.com/news/articles/2025-11-13/pfizer-looks-to-sell-stake-in-pandemic-vaccine-partner-biontech